Abstract
The role of ascitic fluid collagen in the pathogenesis of the coagulopathy that follows peritoneovenous shunting was examined. Collagen was partially purified from ascitic fluid and infused into rabbits. All animals developed changes in their haemostatic profile consistent with intravascular coagulation. Aspirin therapy, for five days before the collagen infusion, prevented these changes. Seven patients undergoing a total of eight peritoneovenous shunts for intractable ascites received antiplatelet therapy (aspirin and dipyridamole) in the immediate pre- and postoperative period. After six shunts no thrombocytopenia or prolongation of clotting times developed to suggest decompensated consumptive coagulopathy. Complicating factors may have contributed to the deterioration in haemostasis in the other two patients. There was no early shunt occlusion. The results support the hypothesis that ascitic fluid collagen is important in the pathogenesis of intravascular coagulation postascitic fluid infusion and indicate that antiplatelet drugs may be of value in preventing this complication.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ansley J. D., Bethel R. A., Bowen P. A., 2nd, Warren W. D. Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites. Surgery. 1978 Feb;83(2):181–187. [PubMed] [Google Scholar]
- Gibson P. R., Dudley F. J., Jakobovits A. W., Salem H. H., McInnes I. E. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt. Aust N Z J Med. 1981 Feb;11(1):8–12. [PubMed] [Google Scholar]
- Harmon D. C., Demirjian Z., Ellman L., Fischer J. E. Disseminated intravascular coagulation with the peritoneovenous shunt. Ann Intern Med. 1979 May;90(5):774–776. doi: 10.7326/0003-4819-90-5-774. [DOI] [PubMed] [Google Scholar]
- Hoefs J., Barnes T., Halle P. Intraperitoneal coagulation in chronic liver disease ascites. Dig Dis Sci. 1981 Jun;26(6):518–522. doi: 10.1007/BF01308100. [DOI] [PubMed] [Google Scholar]
- Jobin F. Acetylsalicylic acid, hemostasis and human thromboembolism. Semin Thromb Hemost. 1978 Winter;4(3):199–240. doi: 10.1055/s-0028-1087133. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Majerus P. W., Miletich J. P. Relationships between platelets and coagulation factors in hemostasis. Annu Rev Med. 1978;29:41–49. doi: 10.1146/annurev.me.29.020178.000353. [DOI] [PubMed] [Google Scholar]
- Odegård O. R. Evaluation of an amidolytic heparin cofactor assay method. Thromb Res. 1975 Aug;7(2):351–360. doi: 10.1016/0049-3848(75)90193-0. [DOI] [PubMed] [Google Scholar]
- Salem H. H., Koutts J., Handley C., van Der Weyden M. B., Dudley F. J., Firkin B. G. The aggregation of human platelets by ascitic fluid: a possible mechanism for disseminated intravascular coagulation complicating LeVeen shunts. Am J Hematol. 1981 Sep;11(2):153–157. doi: 10.1002/ajh.2830110206. [DOI] [PubMed] [Google Scholar]
- Stein S. F., Fulenwider J. T., Ansley J. D., Evatt B. L., Nordlinger B., McLemore P., Schwotzer L., Wideman C. S. Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med. 1981 Aug;141(9):1149–1151. [PubMed] [Google Scholar]
- Trelstad R. L., Catanese V. M., Rubin D. F. Collagen fractionation: separation of native types I, II and III by differential precipitation. Anal Biochem. 1976 Mar;71(1):114–118. doi: 10.1016/0003-2697(76)90016-6. [DOI] [PubMed] [Google Scholar]
- Walsh P. N. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII. Br J Haematol. 1972 Apr;22(4):393–405. doi: 10.1111/j.1365-2141.1972.tb05687.x. [DOI] [PubMed] [Google Scholar]